My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 183

    1.

    Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency.

    Schwartz BS, Williams EC, Conlan MG, Mosher DF.

    Ann Intern Med. 1986 Dec;105(6):873-7.PMID: 3465267 [PubMed - indexed for MEDLINE]Related articles

    2.

    Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients.

    Wassenaar T, Black J, Kahl B, Schwartz B, Longo W, Mosher D, Williams E.

    Hematol Oncol. 2008 Dec;26(4):241-6.PMID: 18613223 [PubMed - indexed for MEDLINE]Related articles

    3.

    Plasma alpha 2-antiplasmin activity. Role in the evaluation and management of fibrinolytic states and other bleeding disorders.

    Williams EC.

    Arch Intern Med. 1989 Aug;149(8):1769-72.PMID: 2475079 [PubMed - indexed for MEDLINE]Related articles

    4.

    Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis.

    Meyer K, Williams EC.

    Am J Med. 1985 Sep;79(3):394-6.PMID: 4036990 [PubMed - indexed for MEDLINE]Related articles

    5.

    Epsilon-aminocaproic acid (EACA).

    Griffin JD, Ellman L.

    Semin Thromb Hemost. 1978 Summer;5(1):27-40.PMID: 568312 [PubMed - indexed for MEDLINE]Related articles

    6.

    epsilon-Amino-caproic acid in the management of acute promyelocytic leukaemia.

    Keane TJ, Gorman AM, O'Connell LG, Fennelly JJ.

    Acta Haematol. 1976;56(4):202-4.PMID: 826076 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Antiplasmin drugs and factor XIII concentrates in the treatment of a patient with acute promyelocytic leukemia (M3)]

    Ryo R, Sugano W, Yoshida A, Adachi M, Yasunaga M, Yoneda N, Saigo K, Kondo S, Yamaguchi N, Nobusawa A, et al.

    Gan No Rinsho. 1989 Oct;35(12):1479-82. Japanese. PMID: 2810783 [PubMed - indexed for MEDLINE]Related articles

    8.

    Successful treatment of skeletal hemangioma and Kasabach-Merritt syndrome with aminocaproic acid. Is fibrinolysis "defensive"?

    Neidhart JA, Roach RW.

    Am J Med. 1982 Sep;73(3):434-8.PMID: 7124770 [PubMed - indexed for MEDLINE]Related articles

    9.

    Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemia.

    Kahle LH, Avvisati G, Lamping RJ, Moretti T, Mandelli F, ten Cate JW.

    Scand J Clin Lab Invest Suppl. 1985;178:75-80.PMID: 2418490 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Use of protamine sulfate, epsilon-aminocaproic acid and serotonin in experimental hypofibrinogenemia and fibrinolysis caused by stimulation of the anticoagulant system]

    Kalishevskaia TM, Pochukaeva LS.

    Nauchnye Doki Vyss Shkoly Biol Nauki. 1976;(10):69-75. Russian. No abstract available. PMID: 139174 [PubMed - indexed for MEDLINE]Related articles

    11.

    Direct evidence for systemic fibrinogenolysis in patients with acquired alpha 2-plasmin inhibitor deficiency.

    Okajima K, Kohno I, Soe G, Okabe H, Takatsuki K, Binder BR.

    Am J Hematol. 1994 Jan;45(1):16-24.PMID: 8250008 [PubMed - indexed for MEDLINE]Related articles

    12.

    Clinical disorders of fibrinolysis: a critical review.

    Francis RB Jr.

    Blut. 1989 Jul;59(1):1-14. Review.PMID: 2526671 [PubMed - indexed for MEDLINE]Related articles

    13.

    In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.

    Dombret H, Scrobohaci ML, Daniel MT, Micléa JM, Castaigne S, Chomienne C, Fenaux P, Degos L.

    Leukemia. 1995 Jan;9(1):19-24.PMID: 7531260 [PubMed - indexed for MEDLINE]Related articles

    14.

    Primary pathological fibrinolysis in viper (Echis-Carinatus) bite treatment by epsilon aminocaproic acid.

    Shah PK, Chittora MD, Vyas MM, Tak RS, Vyas R.

    J Assoc Physicians India. 1987 Sep;35(9):654-5. No abstract available. PMID: 3436935 [PubMed - indexed for MEDLINE]Related articles

    15.

    Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation.

    Takahashi H, Hanano M, Takizawa S, Tatewaki W, Shibata A.

    Am J Hematol. 1988 Jul;28(3):162-6.PMID: 2457307 [PubMed - indexed for MEDLINE]Related articles

    16.

    Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation.

    Kang Y, Lewis JH, Navalgund A, Russell MW, Bontempo FA, Niren LS, Starzl TE.

    Anesthesiology. 1987 Jun;66(6):766-73.PMID: 3296855 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Disseminated intravascular coagulation and excessive fibrinolysis in a patient with metastatic prostate cancer. Response to epsilon-aminocaproic acid.

    Cooper DL, Sandler AB, Wilson LD, Duffy TP.

    Cancer. 1992 Aug 1;70(3):656-8.PMID: 1623480 [PubMed - indexed for MEDLINE]Related articles

    18.

    A bleeding disorder due to deficiency of alpha 2-antiplasmin.

    Kettle P, Mayne EE.

    J Clin Pathol. 1985 Apr;38(4):428-9.PMID: 3988955 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    [Correction of hemostasis following thrombosis of arteriovenous aneurysms of the brain]

    Sukhanov VA, Suslov SA.

    Zh Vopr Neirokhir Im N N Burdenko. 1983 Jan-Feb;(1):20-3. Russian. No abstract available. PMID: 6837205 [PubMed - indexed for MEDLINE]Related articles

    20.

    Congenital alpha(2)-plasmin inhibitor deficiencies: a review.

    Favier R, Aoki N, de Moerloose P.

    Br J Haematol. 2001 Jul;114(1):4-10. Review. No abstract available. PMID: 11472338 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity